XTX Topco’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$124K Sell
47,151
-57,307
-55% -$135K ﹤0.01% 3029
2025
Q4
$200K Sell
104,458
-45,504
-30% -$108K 0.01% 2402
2025
Q3
$333K Buy
149,962
+41,684
+38% +$100K 0.02% 1427
2025
Q2
$155K Buy
108,278
+68,178
+170% +$99.2K 0.01% 1780
2025
Q1
$64.2K Buy
+40,100
New +$120K ﹤0.01% 1956
2024
Q4
Sell
-84,951
Closed -$484K 2348
2024
Q3
$484K Buy
+84,951
New +$511K 0.04% 842
2024
Q1
Sell
-21,203
Closed -$120K 1877
2023
Q4
$120K Sell
21,203
-74,839
-78% -$171K 0.03% 1095
2023
Q3
$179K Sell
96,042
-104,991
-52% -$320K 0.03% 1053
2023
Q2
$553K Buy
201,033
+167,194
+494% +$537K 0.1% 308
2023
Q1
$106K Buy
33,839
+19,685
+139% +$116K 0.02% 1091
2022
Q4
$83.5K Buy
14,154
+1,605
+13% +$13.3K 0.02% 1016
2022
Q3
$110K Buy
+12,549
New +$130K 0.03% 930

Other funds holding CCCC